| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9384 |
| Human Intestinal Absorption | HIA+ | 0.8859 |
| Caco-2 Permeability | Caco2- | 0.5231 |
| P-glycoprotein Substrate | Non-substrate | 0.8815 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9756 |
| Non-inhibitor | 0.9941 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9367 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4999 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8582 |
| CYP450 2D6 Substrate | Non-substrate | 0.8857 |
| CYP450 3A4 Substrate | Non-substrate | 0.7957 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8470 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8644 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9085 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8929 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9219 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9345 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9156 |
| Non-inhibitor | 0.9675 |
| AMES Toxicity | AMES toxic | 0.8837 |
| Carcinogens | Carcinogens | 0.7711 |
| Fish Toxicity | Low FHMT | 0.9387 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7487 |
| Honey Bee Toxicity | High HBT | 0.7089 |
| Biodegradation | Not ready biodegradable | 0.6341 |
| Acute Oral Toxicity | II | 0.7103 |
| Carcinogenicity (Three-class) | Non-required | 0.6243 |